The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRB..L Share News (RB.)

  • There is currently no data for RB.

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TOP NEWS: Reckitt Lifts 2020 Outlook As It Gets Stockpiling Boost

Thu, 30th Apr 2020 09:35

(Alliance News) - Reckitt Benckiser Group PLC on Thursday posted a double-digit first quarter revenue rise amid higher sales of hygiene and health products as a result of the virus pandemic, with the Dettol maker even nudging its 2020 outlook higher.

Reckitt said its "2020 performance is now expected to be better than original expectations" but conceded the "outlook for the balance of 2020 remains uncertain".

Total Reckitt sales climbed 12% to GBP3.54 billion in the quarter to March 31. On a like-for-like basis, sales were 13% higher.

The largest sales rise came from over-the-counter health products. These jumped by about a third to GBP618 million.

It helped the FTSE 100 company to a 13% sales hike in the Health unit to GBP2.19 billion.

In Hygiene, sales jumped 11% to GBP1.36 billion.

The "unfolding health crisis", led to shifts in consumer spending patterns, as many stocked up on goods now, in fear of shortages further down the line.

"The unfolding health crisis is an unprecedented situation for our global community and our thoughts are with those most affected, either on the front-line or dealing with the domestic and societal impacts of Covid-19," Reckitt said.

"RB is uniquely positioned to help build healthier communities with a portfolio that includes not only leading brands such as Dettol and Lysol, which break the chain of infection, but also Mucinex, Lemsip, Durex, Nurofen and Strepsils, as well as our Nutrition portfolio."

Last Friday, Reckitt warned that under "no circumstance" should disinfectants be injected or consumed, following comments made by Donald Trump. The US president suffered a backlash after suggesting it would be "interesting to check" whether a disinfectant injection could help combat coronavirus.

Although expecting a better 2020 than initially anticipated, Reckitt warned operating costs willl be higher, "particularly in our supply chain, as we keep our people safe, mitigate disruptions and serve the needs of our consumers".

Shares in the company were 4.3% higher at 6,680.00 pence each in London on Thursday morning.

By Eric Cunha; ericcunha@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
27 Nov 2020 11:56

TOP NEWS: Reckitt Submits GBP1 Billion Claim Against Indivior

TOP NEWS: Reckitt Submits GBP1 Billion Claim Against Indivior

Read more
27 Nov 2020 11:44

Indivior tumbles as Reckitt Benckiser makes £1bn claim

(Sharecast News) - Indivior shares tumbled on Friday after the opioid addiction treatment maker said it had been made aware of a £1.07bn claim against it by consumer goods company Reckitt Benckiser.

Read more
25 Nov 2020 16:44

UK DIRECTOR DEALINGS SUMMARY: IG Design Chair Banks GBP1.2 Million

UK DIRECTOR DEALINGS SUMMARY: IG Design Chair Banks GBP1.2 Million

Read more
25 Nov 2020 16:23

Director dealings: Reckitt Benckiser CEO ups stake

(Sharecast News) - Reckitt Benckiser revealed on Wednesday that chief executive Laxman Narasimhan had acquired 7,930 ordinary shares in the FTSE 200-listed Dettol maker.

Read more
24 Nov 2020 06:44

DIRECTOR DEALINGS: Reckitt Benckiser Chair Buys GBP250,000 In Shares

DIRECTOR DEALINGS: Reckitt Benckiser Chair Buys GBP250,000 In Shares

Read more
19 Nov 2020 13:38

Thursday broker round-up

(Sharecast News) - easyJet: Liberum upgrades to buy with a target price of 1,300p.

Read more
19 Nov 2020 12:42

Jefferies downgrades Reckitt, says vaccine rollout alters landscape

(Sharecast News) - Jefferies downgraded its rating on shares of consumer goods giant and Dettol maker Reckitt Benckiser on Thursday to 'underperform' from 'hold' and slashed the price target to 5,845p from 7,100p.

Read more
19 Nov 2020 09:55

UK BROKER RATINGS SUMMARY: Liberum Upgrades easyJet, Davy Downgrades

UK BROKER RATINGS SUMMARY: Liberum Upgrades easyJet, Davy Downgrades

Read more
16 Nov 2020 11:56

LONDON MARKET MIDDAY: Momentum Continues On Vaccine Hopes, Upbeat Data

LONDON MARKET MIDDAY: Momentum Continues On Vaccine Hopes, Upbeat Data

Read more
13 Nov 2020 17:25

UPDATE 2-FTSE 100 dips but still posts best week since April on vaccine hopes

(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window)* UK-EU to resume Brexit trade talks on Monday* Galliford surges on return to profitability forecast* Whitbread jumps on Barclays' upgrade to...

Read more
11 Nov 2020 09:45

UK BROKER RATINGS SUMMARY: Goldman Sachs And BofA Both Lift IAG To Buy

UK BROKER RATINGS SUMMARY: Goldman Sachs And BofA Both Lift IAG To Buy

Read more
6 Nov 2020 09:36

UK BROKER RATINGS SUMMARY: Panmure Says Buy AVEVA, Hold RSA

UK BROKER RATINGS SUMMARY: Panmure Says Buy AVEVA, Hold RSA

Read more
6 Nov 2020 08:22

LONDON BRIEFING: RSA Insurance Backs GBP7 Billion Buy And Divide Plan

LONDON BRIEFING: RSA Insurance Backs GBP7 Billion Buy And Divide Plan

Read more
23 Oct 2020 09:29

UK BROKER RATINGS SUMMARY: Reckitt Lifted; Liberum Resumes IAG At Hold

UK BROKER RATINGS SUMMARY: Reckitt Lifted; Liberum Resumes IAG At Hold

Read more
22 Oct 2020 13:59

Thursday broker round-up

(Sharecast News) - Abcam: Berenberg downgrades to hold with a target price of 1,180p.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.